{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:40:49Z","timestamp":1788349249466,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-026-00853-5","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:52:58Z","timestamp":1779691978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunoinformatic design of a multi-epitope vaccine candidate targeting multidrug-resistant Pseudomonas aeruginosa"],"prefix":"10.1186","volume":"27","author":[{"given":"Maryam","family":"Babaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Shahbazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Sarkoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Azadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia Jafari","family":"Ranjbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadijeh","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"853_CR1","doi-asserted-by":"publisher","first-page":"1114199","DOI":"10.3389\/fmicb.2022.1114199","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, et al. Pseudomonas aeruginosa: A typical biofilm forming pathogen and an emerging but underestimated pathogen in food processing. Front Microbiol. 2022;13:1114199.","journal-title":"Front Microbiol"},{"issue":"5","key":"853_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3390\/antibiotics14050509","volume":"14","author":"HI Al-Daghistani","year":"2025","unstructured":"Al-Daghistani HI, Abu-Niaaj LF, Zein S. Accurate Diagnosis of Pseudomonas aeruginosa Is Critical to Mitigating Development of Antibiotic Resistance. Antibiotics. 2025;14(5):509.","journal-title":"Antibiotics"},{"key":"853_CR3","doi-asserted-by":"publisher","unstructured":"Kothari A, et al. Age of Antibiotic Resistance in MDR\/XDR Clinical Pathogen of Pseudomonas aeruginosa. Pharmaceuticals. 2023;16. https:\/\/doi.org\/10.3390\/ph16091230.","DOI":"10.3390\/ph16091230"},{"key":"853_CR4","doi-asserted-by":"publisher","unstructured":"Schwartz B, et al. Multidrug Resistant Pseudomonas aeruginosa in Clinical Settings: A Review of Resistance Mechanisms and Treatment Strategies. Pathogens. 2024;13. https:\/\/doi.org\/10.3390\/pathogens13110975.","DOI":"10.3390\/pathogens13110975"},{"key":"853_CR5","doi-asserted-by":"publisher","unstructured":"Zakhour J, et al. Antimicrobial Treatment of Pseudomonas aeruginosa Severe Sepsis. Antibiot (Basel). 2022;11(10):1432. https:\/\/doi.org\/10.3390\/antibiotics11101432.","DOI":"10.3390\/antibiotics11101432"},{"key":"853_CR6","unstructured":"Organization WH. WHO Bacterial Priority Pathogens List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. Report."},{"key":"853_CR7","doi-asserted-by":"publisher","unstructured":"Killough M, Rodgers AM, Ingram RJ. Pseudomonas aeruginosa: Recent Advances in Vaccine Development. Vaccines (Basel). 2022;10(7):1100. https:\/\/doi.org\/10.3390\/vaccines10071100.","DOI":"10.3390\/vaccines10071100"},{"issue":"9","key":"853_CR8","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3390\/vaccines12090992","volume":"12","author":"S Stepkowski","year":"2024","unstructured":"Stepkowski S, et al. The major role of t regulatory cells in the efficiency of vaccination in general and immunocompromised populations: a review. Vaccines. 2024;12(9):992.","journal-title":"Vaccines"},{"issue":"2","key":"853_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s10989-020-10134-3","volume":"27","author":"FN Zargaran","year":"2021","unstructured":"Zargaran FN, et al. B cell epitopes of four fimbriae antigens of Klebsiella pneumoniae: a comprehensive in silico study for vaccine development. Int J Pept Res Ther. 2021;27(2):875\u201386.","journal-title":"Int J Pept Res Ther"},{"issue":"4","key":"853_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/icb.1997.63","volume":"75","author":"A Suhrbier","year":"1997","unstructured":"Suhrbier A. Multi-epitope DNA vaccines. Immunol Cell Biol. 1997;75(4):402\u20138.","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"853_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.imlet.2004.11.009","volume":"97","author":"J Holmgren","year":"2005","unstructured":"Holmgren J, et al. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol Lett. 2005;97(2):181\u20138.","journal-title":"Immunol Lett"},{"key":"853_CR12","doi-asserted-by":"publisher","unstructured":"Sethi A, et al. Cell type and receptor identity regulate cholera toxin subunit B (CTB) internalization. Interface Focus. 2019;9(2):20180076. https:\/\/doi.org\/10.1098\/rsfs.2018.0076.","DOI":"10.1098\/rsfs.2018.0076"},{"issue":"1","key":"853_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4161\/hv.34296","volume":"11","author":"K Grimwood","year":"2015","unstructured":"Grimwood K, et al. Vaccination against respiratory Pseudomonas aeruginosa infection. Hum vaccines immunotherapeutics. 2015;11(1):14\u201320.","journal-title":"Hum vaccines immunotherapeutics"},{"issue":"6","key":"853_CR14","doi-asserted-by":"publisher","first-page":"111617","DOI":"10.1016\/j.humimm.2025.111617","volume":"86","author":"AI Al-Harbi","year":"2025","unstructured":"Al-Harbi AI, et al. In silico Identification of novel vaccine candidates against Multidrug-Resistant Pseudomonas aeruginosa using subtractive proteomics and immunoinformatics. Hum Immunol. 2025;86(6):111617.","journal-title":"Hum Immunol"},{"issue":"2","key":"853_CR15","first-page":"670","volume":"70","author":"P Kumar","year":"2023","unstructured":"Kumar P, Shiraz M, Akif M. Multiepitope-based vaccine design by exploring antigenic potential among leptospiral lipoproteins using comprehensive immunoinformatics and structure\u2010based approaches. Biotechnol Appl Chem. 2023;70(2):670\u201387.","journal-title":"Biotechnol Appl Chem"},{"key":"853_CR16","doi-asserted-by":"crossref","unstructured":"Yu H et al. Type III secretion protein, PcrV, impairs Pseudomonas aeruginosa biofilm formation by increasing M1 macrophage-mediated anti-bacterial activities. Front Microbiol 11: 1971. Bull DA (2014) Cell surface engineering to enhance mesenchymal stem cell migration toward an SDF-1 gradient. Biomaterials. 2020. 35(21):5627\u20135635.","DOI":"10.1016\/j.biomaterials.2014.03.070"},{"issue":"4","key":"853_CR17","doi-asserted-by":"publisher","first-page":"e62735","DOI":"10.1371\/journal.pone.0062735","volume":"8","author":"U Qaisar","year":"2013","unstructured":"Qaisar U, et al. The pvc operon regulates the expression of the Pseudomonas aeruginosa fimbrial chaperone\/usher pathway (cup) genes. PLoS ONE. 2013;8(4):e62735.","journal-title":"PLoS ONE"},{"issue":"31","key":"853_CR18","doi-asserted-by":"publisher","first-page":"pe2107644118","DOI":"10.1073\/pnas.2107644118","volume":"118","author":"J Ude","year":"2021","unstructured":"Ude J, et al. Outer membrane permeability: Antimicrobials and diverse nutrients bypass porins in Pseudomonas aeruginosa. Proc Natl Acad Sci. 2021;118(31):pe2107644118.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"853_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13054-017-1601-9","volume":"21","author":"J Rello","year":"2017","unstructured":"Rello J, et al. A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients. Crit Care. 2017;21(1):22.","journal-title":"Crit Care"},{"issue":"20","key":"853_CR20","doi-asserted-by":"publisher","first-page":"e70907","DOI":"10.1111\/jcmm.70907","volume":"29","author":"SK Mishra","year":"2025","unstructured":"Mishra SK, et al. A Mutation-Based Reverse Vaccinology Approach Considering Variability in Epitopes to Combat Multi-Strains: A Study Using Glycoprotein of LASV. J Cell Mol Med. 2025;29(20):e70907.","journal-title":"J Cell Mol Med"},{"key":"853_CR21","doi-asserted-by":"publisher","first-page":"127883","DOI":"10.1016\/j.molliq.2025.127883","volume":"433","author":"SK Mishra","year":"2025","unstructured":"Mishra SK, et al. Integrated immunoinformatics and reverse vaccinology assisted novel multi-epitope vaccine against Coxsackievirus A10 investigating its whole genome encoded polyprotein. J Mol Liq. 2025;433:127883.","journal-title":"J Mol Liq"},{"key":"853_CR22","doi-asserted-by":"publisher","unstructured":"Coudert E, et al. Annotation of biologically relevant ligands in UniProtKB using ChEBI. Bioinformatics. 2023;1;39(1):btac793. https:\/\/doi.org\/10.1093\/bioinformatics\/btac793.","DOI":"10.1093\/bioinformatics\/btac793"},{"key":"853_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"DoytchinovaI A, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics. 2007;5:8:4. https:\/\/doi.org\/10.1186\/1471-2105-8-4.","journal-title":"BMC Bioinformatics"},{"key":"853_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-1-60327-118-9_13","volume":"409","author":"PA Reche","year":"2007","unstructured":"Reche PA, Reinherz EL. Prediction of peptide-MHC binding using profiles. Methods Mol Biol. 2007;409:185\u2013200.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"853_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/21645515.2019.1703453","volume":"16","author":"C Kruiswijk","year":"2020","unstructured":"Kruiswijk C, et al. In silico identification and modification of T cell epitopes in pertussis antigens associated with tolerance. Hum Vaccin Immunother. 2020;16(2):277\u201385.","journal-title":"Hum Vaccin Immunother"},{"issue":"W1","key":"853_CR26","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","volume":"45","author":"MC Jespersen","year":"2017","unstructured":"Jespersen MC, et al. BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res. 2017;45(W1):W24\u20139.","journal-title":"Nucleic Acids Res"},{"key":"853_CR27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1385\/1-59259-890-0:571","volume-title":"Protein Identification and Analysis Tools on the ExPASy Server, in The Proteomics Protocols Handbook","author":"E Gasteiger","year":"2005","unstructured":"Gasteiger E, et al. Protein Identification and Analysis Tools on the ExPASy Server, in The Proteomics Protocols Handbook. Totowa, NJ: Humana; 2005. pp. 571\u2013607. J.M. Walker, Editor."},{"issue":"2","key":"853_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.6026\/97320630012074","volume":"12","author":"VK Garg","year":"2016","unstructured":"Garg VK, et al. MFPPI - Multi FASTA ProtParam Interface. Bioinformation. 2016;12(2):74\u20137.","journal-title":"Bioinformation"},{"issue":"Suppl 6","key":"853_CR29","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2105-14-S6-S4","volume":"14","author":"I Dimitrov","year":"2013","unstructured":"Dimitrov I, Flower DR, Doytchinova I. AllerTOP\u2013a server for in silico prediction of allergens. BMC Bioinformatics. 2013;14(Suppl 6):S4.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"853_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/bioinformatics\/btaa1102","volume":"37","author":"J Hon","year":"2021","unstructured":"Hon J, et al. SoluProt: prediction of soluble protein expression in Escherichia coli. Bioinformatics. 2021;37(1):23\u20138.","journal-title":"Bioinformatics"},{"issue":"5","key":"853_CR31","doi-asserted-by":"publisher","first-page":"bbac174","DOI":"10.1093\/bib\/bbac174","volume":"23","author":"N Sharma","year":"2022","unstructured":"Sharma N, et al. ToxinPred2: an improved method for predicting toxicity of proteins. Brief Bioinform. 2022;23(5):bbac174.","journal-title":"Brief Bioinform"},{"issue":"2","key":"853_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/prot.10181","volume":"49","author":"A Kloczkowski","year":"2002","unstructured":"Kloczkowski A, et al. Combining the GOR V algorithm with evolutionary information for protein secondary structure prediction from amino acid sequence. Proteins. 2002;49(2):154\u201366.","journal-title":"Proteins"},{"issue":"1","key":"853_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams CJ, et al. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 2018;27(1):293\u2013315.","journal-title":"Protein Sci"},{"key":"853_CR34","doi-asserted-by":"crossref","unstructured":"Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007. 35(Web Server issue):W407\u201310.","DOI":"10.1093\/nar\/gkm290"},{"issue":"9","key":"853_CR35","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 1993;2(9):1511\u20139.","journal-title":"Protein Sci"},{"key":"853_CR36","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/1471-2105-9-514","volume":"9","author":"J Ponomarenko","year":"2008","unstructured":"Ponomarenko J, et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics. 2008;9:514.","journal-title":"BMC Bioinformatics"},{"issue":"13","key":"853_CR37","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605\u201312.","journal-title":"J Comput Chem"},{"issue":"2","key":"853_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bjid.2015.10.011","volume":"20","author":"S Mukherjee","year":"2016","unstructured":"Mukherjee S, Karmakar S, Babu SP. TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review. Braz J Infect Dis. 2016;20(2):193\u2013204.","journal-title":"Braz J Infect Dis"},{"key":"853_CR39","doi-asserted-by":"crossref","unstructured":"Koymans KJ et al. Structural basis for inhibition of TLR2 by staphylococcal superantigen-like protein 3 (SSL3). Proceedings of the National Academy of Sciences. 2015;112(35):11018\u201311023.","DOI":"10.1073\/pnas.1502026112"},{"issue":"30","key":"853_CR40","doi-asserted-by":"publisher","first-page":"e2105316118","DOI":"10.1073\/pnas.2105316118","volume":"118","author":"L Su","year":"2021","unstructured":"Su L, et al. Sulfatides are endogenous ligands for the TLR4\u2013MD-2 complex. Proc Natl Acad Sci. 2021;118(30):e2105316118.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"853_CR41","first-page":"690","volume":"78","author":"G Jones","year":"2022","unstructured":"Jones G, et al. Elucidation of protein function using computational docking and hotspot analysis by ClusPro and FTMap. Biol Crystallogr. 2022;78(6):690\u20137.","journal-title":"Biol Crystallogr"},{"issue":"23","key":"853_CR42","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","volume":"32","author":"LC Xue","year":"2016","unstructured":"Xue LC, et al. PRODIGY: a web server for predicting the binding affinity of protein\u2013protein complexes. Bioinformatics. 2016;32(23):3676\u20138.","journal-title":"Bioinformatics"},{"issue":"12","key":"853_CR43","doi-asserted-by":"publisher","first-page":"e4473","DOI":"10.1002\/pro.4473","volume":"31","author":"RA Laskowski","year":"2022","unstructured":"Laskowski RA. PDBsum 1: A standalone program for generating PDBsum analyses. Protein Sci. 2022;31(12):e4473.","journal-title":"Protein Sci"},{"issue":"W1","key":"853_CR44","doi-asserted-by":"publisher","first-page":"W306","DOI":"10.1093\/nar\/gkaf379","volume":"53","author":"X Zhang","year":"2025","unstructured":"Zhang X, et al. HawkDock version 2: an updated web server to predict and analyze the structures of protein\u2013protein complexes. Nucleic Acids Res. 2025;53(W1):W306\u201315.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"853_CR45","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, et al. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26(16):1701\u201318.","journal-title":"J Comput Chem"},{"issue":"1","key":"853_CR46","doi-asserted-by":"publisher","first-page":"14215","DOI":"10.1038\/s41598-021-93305-6","volume":"11","author":"S Basak","year":"2021","unstructured":"Basak S, et al. In silico designing of vaccine candidate against Clostridium difficile. Sci Rep. 2021;11(1):14215.","journal-title":"Sci Rep"},{"issue":"1","key":"853_CR47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s43141-023-00605-7","volume":"21","author":"I Nuryana","year":"2023","unstructured":"Nuryana I, et al. Codon optimization of a gene encoding DNA polymerase from Pyrococcus furiosus and its expression in Escherichia coli. J Genetic Eng Biotechnol. 2023;21(1):129.","journal-title":"J Genetic Eng Biotechnol"},{"key":"853_CR48","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s10989-020-10134-3","volume":"27","author":"FN Zargaran","year":"2021","unstructured":"Zargaran FN, et al. B cell epitopes of four fimbriae antigens of Klebsiella pneumoniae: a comprehensive in silico study for vaccine development. Int J Pept Res Ther. 2021;27:875\u201386.","journal-title":"Int J Pept Res Ther"},{"issue":"3","key":"853_CR49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.bj.2020.01.002","volume":"44","author":"FA Olotu","year":"2021","unstructured":"Olotu FA, Soliman MES. Immunoinformatics prediction of potential B-cell and T-cell epitopes as effective vaccine candidates for eliciting immunogenic responses against Epstein-Barr virus. Biomed J. 2021;44(3):317\u201337.","journal-title":"Biomed J"},{"key":"853_CR50","doi-asserted-by":"crossref","unstructured":"Mackel JJ et al. T cell immunity to a classical strain of Klebsiella pneumoniae. J Immunol. 2022;208(1_Supplement):170.21-170.21.","DOI":"10.4049\/jimmunol.208.Supp.170.21"},{"issue":"1","key":"853_CR51","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41541-025-01258-y","volume":"10","author":"F Villanueva-Flores","year":"2025","unstructured":"Villanueva-Flores F, Javier I, Sanchez-Villamil, Garcia-Atutxa I. AI-driven epitope prediction: a systematic review, comparative analysis, and practical guide for vaccine development. npj Vaccines. 2025;10(1):207.","journal-title":"npj Vaccines"},{"key":"853_CR52","doi-asserted-by":"publisher","unstructured":"Roy SK, et al. A computational approach to developing a multi-epitope vaccine for combating Pseudomonas aeruginosa-induced pneumonia and sepsis. Brief Bioinform. 2024;25(5):bbae401. https:\/\/doi.org\/10.1093\/bib\/bbae401.","DOI":"10.1093\/bib\/bbae401"},{"issue":"6","key":"853_CR53","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1128\/IAI.00054-09","volume":"77","author":"ET Weimer","year":"2009","unstructured":"Weimer ET, et al. A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa. Infect Immun. 2009;77(6):2356\u201366.","journal-title":"Infect Immun"},{"key":"853_CR54","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2147\/IDR.S244081","volume":"13","author":"MH Fakoor","year":"2020","unstructured":"Fakoor MH, et al. Protective Efficacy of the OprF\/OprI\/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB\/c Mouse Model. Infect Drug Resist. 2020;13:1651\u201361.","journal-title":"Infect Drug Resist"},{"issue":"5","key":"853_CR55","doi-asserted-by":"publisher","first-page":"e0238122","DOI":"10.1128\/mbio.02381-22","volume":"13","author":"E Kundracik","year":"2022","unstructured":"Kundracik E, et al. PopB-PcrV Interactions Are Essential for Pore Formation in the Pseudomonas aeruginosa Type III Secretion System Translocon. mBio. 2022;13(5):e0238122.","journal-title":"mBio"},{"key":"853_CR56","doi-asserted-by":"publisher","first-page":"100044","DOI":"10.1016\/j.health.2022.100044","volume":"2","author":"DD Martinelli","year":"2022","unstructured":"Martinelli DD. In silico vaccine design: A tutorial in immunoinformatics. Healthc Analytics. 2022;2:100044.","journal-title":"Healthc Analytics"},{"key":"853_CR57","doi-asserted-by":"publisher","unstructured":"Abd El-Aziz MB, et al. Virulence Factors and Biofilm Formation in Multi-drug Resistant Pseudomonas Aeruginosa. J Pharm Negat Results. 2023:14(2);3117\u201326. https:\/\/doi.org\/10.47750\/pnr.2023.14.02.367%20.","DOI":"10.47750\/pnr.2023.14.02.367%20"},{"key":"853_CR58","doi-asserted-by":"publisher","unstructured":"Stepkowski S, et al. The Major Role of T Regulatory Cells in the Efficiency of Vaccination in General and Immunocompromised Populations: A Review. Vaccines (Basel). 2024;12(9):992. https:\/\/doi.org\/10.3390\/vaccines12090992.","DOI":"10.3390\/vaccines12090992"},{"issue":"11","key":"853_CR59","doi-asserted-by":"publisher","first-page":"e1012696","DOI":"10.1371\/journal.ppat.1012696","volume":"20","author":"H Zhang","year":"2024","unstructured":"Zhang H, et al. Mucosal immunization with the lung Lactobacillus-derived amphiphilic exopolysaccharide adjuvanted recombinant vaccine improved protection against P. aeruginosa infection. PLoS Pathog. 2024;20(11):e1012696.","journal-title":"PLoS Pathog"},{"issue":"1","key":"853_CR60","first-page":"94","volume":"4","author":"F Al-Khikani","year":"2023","unstructured":"Al-Khikani F. Virulence factors in Pseudomonas aeruginosa: The arms race between bacteria and humans. Microbes Infect Dis. 2023;4(1):94\u20136.","journal-title":"Microbes Infect Dis"},{"key":"853_CR61","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3389\/fmicb.2020.01971","volume":"11","author":"H Yu","year":"2020","unstructured":"Yu H, et al. Type III Secretion Protein, PcrV, Impairs Pseudomonas aeruginosa Biofilm Formation by Increasing M1 Macrophage-Mediated Anti-bacterial Activities. Front Microbiol. 2020;11:1971.","journal-title":"Front Microbiol"},{"key":"853_CR62","doi-asserted-by":"publisher","first-page":"1374466","DOI":"10.3389\/fmicb.2024.1374466","volume":"15","author":"A Elfadadny","year":"2024","unstructured":"Elfadadny A, et al. Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies. Front Microbiol. 2024;15:1374466.","journal-title":"Front Microbiol"},{"key":"853_CR63","doi-asserted-by":"publisher","first-page":"101427","DOI":"10.1016\/j.genrep.2021.101427","volume":"26","author":"C Deshamukhya","year":"2022","unstructured":"Deshamukhya C, et al. Expression of cupA gene cluster responsible for biofilm formation in Pseudomonas aeruginosa is enhanced against subinhibitory concentration of carbapenems. Gene Rep. 2022;26:101427.","journal-title":"Gene Rep"},{"issue":"3","key":"853_CR64","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/molecules25030627","volume":"25","author":"QU Ain","year":"2020","unstructured":"Ain QU, Batool M, Choi S. TLR4-targeting therapeutics: structural basis and computer-aided drug discovery approaches. Molecules. 2020;25(3):627.","journal-title":"Molecules"},{"issue":"1","key":"853_CR65","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13054-020-2792-z","volume":"24","author":"C Adlbrecht","year":"2020","unstructured":"Adlbrecht C, et al. Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trial. Crit Care. 2020;24(1):74.","journal-title":"Crit Care"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-026-00853-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00853-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00853-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:05:37Z","timestamp":1784639137000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12865-026-00853-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["853"],"URL":"https:\/\/doi.org\/10.1186\/s12865-026-00853-5","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"31 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"67"}}